318 related articles for article (PubMed ID: 35106794)
21. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
[TBL] [Abstract][Full Text] [Related]
22. [Plasma exosomal miR-335-5p serves as a diagnostic indicator and inhibits immune escape in triple-negative breast cancer].
Chen T; Dong Y; Wu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):347-356. PubMed ID: 35583065
[TBL] [Abstract][Full Text] [Related]
23. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F
Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969
[TBL] [Abstract][Full Text] [Related]
24. PD-1 blockade and radiotherapy combination for advanced Epstein-Barr virus-associated intrahepatic cholangiocarcinoma: a case report and literature review.
Liao CX; Deng CS; Liang X; Yang JC; Chen ZZ; Lin XY; Lin CF; Chen S; Wu SS
Front Immunol; 2023; 14():1239168. PubMed ID: 37753076
[TBL] [Abstract][Full Text] [Related]
25. Exosomal miR-6733-5p mediates cross-talk between glioblastoma stem cells and macrophages and promotes glioblastoma multiform progression synergistically.
Huang S; Liu L; Xu Z; Liu X; Wu A; Zhang X; Li Z; Li S; Li Y; Yuan J; Cheng S; Li H; Dong J
CNS Neurosci Ther; 2023 Dec; 29(12):3756-3773. PubMed ID: 37309294
[TBL] [Abstract][Full Text] [Related]
26. LKB1 inhibits intrahepatic cholangiocarcinoma by repressing the transcriptional activity of the immune checkpoint PD-L1.
Liu Z; Li S; Zeng J; Zhou X; Li H; Liu X; Li F; Jiang B; Zhao M; Ma T
Life Sci; 2020 Sep; 257():118068. PubMed ID: 32653521
[TBL] [Abstract][Full Text] [Related]
27. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma.
Zhang M; Yang H; Wan L; Wang Z; Wang H; Ge C; Liu Y; Hao Y; Zhang D; Shi G; Gong Y; Ni Y; Wang C; Zhang Y; Xi J; Wang S; Shi L; Zhang L; Yue W; Pei X; Liu B; Yan X
J Hepatol; 2020 Nov; 73(5):1118-1130. PubMed ID: 32505533
[TBL] [Abstract][Full Text] [Related]
28. PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome.
Tian L; Ma J; Ma L; Zheng B; Liu L; Song D; Wang Y; Zhang Z; Gao Q; Song K; Wang X
World J Surg Oncol; 2020 Nov; 18(1):303. PubMed ID: 33228682
[TBL] [Abstract][Full Text] [Related]
29. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
[TBL] [Abstract][Full Text] [Related]
30. Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation.
Shu L; Li X; Liu Z; Li K; Shi A; Tang Y; Zhao L; Huang L; Zhang Z; Zhang D; Huang S; Lian S; Sheng G; Yan Z; Zhang Z; Xu Y
Hepatology; 2024 Feb; 79(2):307-322. PubMed ID: 37140231
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer cells synergistically defend against CD8
Li D; Zhou X; Xu W; Chen Y; Mu C; Zhao X; Yang T; Wang G; Wei L; Ma B
Cancer Med; 2023 Aug; 12(15):16405-16415. PubMed ID: 37501397
[TBL] [Abstract][Full Text] [Related]
32. Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinoma.
Tao L; Wang Y; Shen Z; Cai J; Zheng J; Xia S; Lin Z; Wan Z; Qi H; Jin R; Wang L; Xu J; Liang X
Hepatol Int; 2024 Feb; 18(1):91-107. PubMed ID: 37349627
[TBL] [Abstract][Full Text] [Related]
33. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
[TBL] [Abstract][Full Text] [Related]
34. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
[TBL] [Abstract][Full Text] [Related]
35. Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway.
Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X
Front Immunol; 2020; 11():2026. PubMed ID: 33162971
[TBL] [Abstract][Full Text] [Related]
36. Exosomal miRNA-16-5p Derived From M1 Macrophages Enhances T Cell-Dependent Immune Response by Regulating PD-L1 in Gastric Cancer.
Li Z; Suo B; Long G; Gao Y; Song J; Zhang M; Feng B; Shang C; Wang D
Front Cell Dev Biol; 2020; 8():572689. PubMed ID: 33330451
[TBL] [Abstract][Full Text] [Related]
37. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression.
Li M; Xu H; Qi Y; Pan Z; Li B; Gao Z; Zhao R; Xue H; Li G
Oncogene; 2022 Oct; 41(41):4618-4632. PubMed ID: 36085418
[TBL] [Abstract][Full Text] [Related]
38. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
[TBL] [Abstract][Full Text] [Related]
39. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma.
Mocan LP; Craciun R; Grapa C; Melincovici CS; Rusu I; Al Hajjar N; Sparchez Z; Leucuta D; Ilies M; Sparchez M; Mocan T; Mihu CM
Cancer Immunol Immunother; 2023 Apr; 72(4):1003-1014. PubMed ID: 36251029
[TBL] [Abstract][Full Text] [Related]
40. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.
Wang C; Li X; Zhang L; Chen Y; Dong R; Zhang J; Zhao J; Guo X; Yang G; Li Y; Gu C; Xi Q; Zhang R
Int Immunopharmacol; 2021 Aug; 97():107822. PubMed ID: 34098485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
